Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Weight loss with GLP 1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Obesity and Weight Loss Strategies for Patients With Heart Failure JACC: Heart Failure Understanding Cagrilintide: Benefits and Uses Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as